期刊文献+

组织因子途径抑制物基因多态性在肺栓塞中的研究 被引量:2

The gene polymorphism of tissue factor pathway inhibitor in pulmonary thromboemlism:a correlation study
下载PDF
导出
摘要 目的探讨组织因子途径抑制物(TFPI)基因多态性与肺血栓栓塞症(PTE)的关系。方法选择PTE患者35例,健康对照组34名。采用聚合酶链反应(PCR/RT-PCR)检测PTE组和健康对照组TFPIC-399T、T-287C基因型及等位基因频率,结果经测序证实。结果 PTE组C-399T纯合突变型TT、杂合子突变型CT和正常纯合子CC与健康对照组之间差异无统计学意义(P>0.05);T和C等位基因型频率与健康对照组比较差异无统计学意义。PTE组T287-C杂合子突变型CT、纯合突变CC和正常纯合子CC与健康对照组比较差异无统计学意义(P>0.05);T和C等位基因频率分布与对照组比较,差异也无统计学意义(P>0.05)。结论 TFPI基因C-399T、T287-C多态性可能与PTE无相关性。 Objective To explore the correlation between the gene polymorphism of tissue factor pathway inhibitor(TFPI) and pulmonary thromboemlism(PTE).Methods Thirty-five PTE patients were recuited,with 34 healthy people assigned as normal controls.TFPI C-399T and T-287C genotypes and the allele frequencies were detected in the PTE group and the normal control group by RT-PCR.The results were then verified by sequencing.Results There was no significant difference in C-399T homozygous mutant TT,heterozygote-mutant CT and normal homozygote CC between PTE and normal control groups(P〉0.05).No statistical difference was found in T and C allele frequencies between these two groups.Compared with the normal control group,PTE group showed no statistaical difference in T287-C heterozygote-mutant CT,homozygous mutant CC and normal homozygote CC(P〉0.05).In addition,no difference was found in distribution of T and C allele frequencies in the two groups(P〉0.05).Conclusion There might be no correlation between gene polymorphism of TFPI genetypes(C-399T plus T287-C) and PTE.
出处 《中国药物与临床》 CAS 2011年第7期758-762,共5页 Chinese Remedies & Clinics
基金 山西省自然科学基金(2010011050-6)
关键词 多态性 单核苷酸 肺栓塞 组织因子途径抑制物 Polymorphism single nucleotide Pulmonary embolism Tissue factor pathway inhibitor
  • 相关文献

参考文献16

  • 1Simpson D,Siddiqui MA,Scott LJ,et al. Spotlight on reteplase in thrombotic occlusive disorders. Bio Drugs, 2007,21 ( 1 ) : 65-68. 被引量:1
  • 2Galie N,Gorge G,Herold C,et al. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J, 2000,21 (16):1301. 被引量:1
  • 3Broze GJ Tr. Tissue fact or pathway inhibitor. Thromb Haemost, 1995,74: 90. 被引量:1
  • 4Lincdahl A,Sandset P,Abildgard U. The present status of tissue factor pathway inhibitor. Blood Coag Fibrinolysis, 1992,3:439. 被引量:1
  • 5Golino P. The inhibitor of the tissue factor: factor Ⅶ pathway. Thrumb Res, 2002,106 ( 3 ) : 257-651. 被引量:1
  • 6Lindmark E,Siegbahn A. Tissue fator regulation and cytokine ex- pression in monocyte-endothelial cell co-cuhuree:effects of a statin,an ACE-inhibitor and a low-molecular-weight heparin. Thromb Res, 2002,108 : 77-84. 被引量:1
  • 7Girard TJ,Eddy R,Wesselschmidt RL,et al. Structure of the hu- man lipoprotein associated coagulation inhibitor gene: intro/exon gene organization and localization of the gene/o chromosome. J Bio Chem, 1991,266(8) : 5036-5041. 被引量:1
  • 8Enjyoji K,Emi M,Mukai T,et al. Human tissue factor pathway inhibitor (TFPI) gene: complete genomic structure and localiza- tion in the genetic map of chromosome 2q. Genomics, 1993,17 (2) :423-428. 被引量:1
  • 9Morange PE,Renueci JF,Charles MA,et al. Plasma levels of free and total TFPI,relationgship with cardiovascular risk factors andendothelial cellmarkers. Thromb Haemost,2001,85 (6):999- 1003. 被引量:1
  • 10Saigo M,Abe S,Ogawa M, et al. Imbalance of plasminogen acti- vator inhibitor-1 tissue plasminogen activator and tissue factor tissue factor pathway inhibitor in young Japanese men with my- ocardial infarction. Thromb Haemost,2001,86(5) : 1197-1203. 被引量:1

同被引文献46

  • 1杨芳,王冠军,李薇,王学锋,丁秋兰,王鸿利.抗凝血酶基因A9850G突变导致一个新的遗传性抗凝血酶缺陷症家系[J].检验医学,2006,21(1):18-21. 被引量:7
  • 2高元明,徐秋芬,丁少芳,徐洁.高同型半胱氨酸血症与肺血栓栓塞症的关联及叶酸干预的价值[J].心肺血管病杂志,2006,25(1):16-17. 被引量:3
  • 3Charafeddine KM, Mahfouz RA, Ibrahim GY, et al. Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene muta- tions in a young patient on oral contraceptive pills: A case report [ J ]. Clinical and Ap- plied Thrombosis/Hemostasis, 2010, 16 (5) : 594 - 598. 被引量:1
  • 4Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of protein C in congenital thrombotic disease [ J ]. Journal of Clinical Investigation, 1981, 68 (5): 1370-1373. 被引量:1
  • 5Caspers M, Pavlova A, Driesen J, et al. Deficiencies of antithrombin, protein C and protein S - practical experience in genetic a- nalysis of a large patient cohort [ J ]. Throm- bosis and haemostasis, 2012, 108 ( 2 ) : 247 - 57. 被引量:1
  • 6Bereczky Z, Kovacs KB, Muszbek L Protein C and protein S deficiencies: Similarities and differences between two brothers playing in the same game [ J]. Clinical Chemistry and La- boratory Medicine, 2010, 48 (Suppll):S53 - S66. 被引量:1
  • 7Reitsma PH, Poort SR, Bernardi F, et al. Protein C deficiency: A database of muta- tions. For the Protein C & S Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis [ J ]. Thrombosis and haemosta- sis, 1993, 69 (1): 77-84. 被引量:1
  • 8Mackie I, Cooper P, Lawrie A, et al. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis [ J ]. In- ternational Journal of Laboratory Hematology, 2013, 35 (1): 1-13. 被引量:1
  • 9Ding Q, Shen W, Ye X, et al. Clinical and genetic features of protein C deficiency in 23 unrelated Chinese patients [ J ]. Blood Cells, Molecules, and Diseases, 2013, 50 ( 1 ) : 53 -58. 被引量:1
  • 10Zhu T, Ding Q, Bai X, et al. Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese popula- tion. Results of the Chinese Hemostasis Investi- gation on Natural Anticoagulants Study I Group [J]. Haematologiea, 2011, 96 (7): 1033 - 1040. 被引量:1

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部